10X Genomics outperformed the S&P 500 by 10.9% on August 22, 2025.
2 reports, 2 independent
Updated Aug 22
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
10X Genomics outperformed the S&P 500 by 10.9% on August 22, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.10X Genomics stock significantly outperformed the S&P 500 index.1 source
10X Genomics stock outperformed the S&P 500 on Aug 8, 2025.1 source
Keep exploring
The entities involved
-
10X Genomics
American biotechnology company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- StockStory3 Reasons TXG is Risky and 1 Stock to Buy Instead Over the past six months, 10x Genomics has been a great trade, beating the S&P 500 by 10.9%. Its stock price has climbed to $13.25, representing a he
- Zacks10x Genomics (TXG) Reports Q2 Earnings: What Key Metrics Have to Say For the quarter ended June 2025, 10x Genomics (TXG) reported revenue of $172.91 million, up 12.9% over the same period last year.